|
Abreast Of Ear, Nose &
Throat / Head & Neck Advances
9,March, 2006
|
|
Hello, All. Welcome
to this week's ORL Update. I spent the entire day
receiving birthday wishes that I almost forgot the
newsletter is almost belated by 5 days! I do hope you
find the pick for this edition useful |
|
|
|
Biodun Olusesi,
Newsletter Editor |
OME and COX-2.......?
The quest to
probe the causative factors in OME was taken to
the next dimension recently when attempts were
made to investigate the relationship between the
cyclooxygenase-2 enzyme - known to catalyze
the synthesis of prostaglandins - and serous
otitis media.
Masachi Kakiuchi
et al
(American
Journal of Otolaryngology–Head and Neck Medicine
and Surgery 27 (2006) 81– 85)
studied COX-2 expression in experimental mice OME
models and concluded that COX-2 may be a
contributing factor in pathogenesis of OME, with
an implication for future role of COX-2 inhibitors
in management of OME.
Abstract:
Objectives:
To study
whether cyclooxygenase 2 (COX-2) plays a role in
the development of otitis media with effusion
(OME).
Study
design/methods:
An
experimental model of endotoxin-induced OME was
used in healthy BALB/c mice. Solutions of
Salmonella
typhimurium
endotoxin were
injected into the middle ears of the mice, and
COX-2 expression in the middle ears was studied
using reverse transcription– polymerase chain
reaction (RT-PCR) and in situ hybridization (ISH).
Results:
Analysis by
RT-PCR showed that COX-2 expression in the middle
ear increased in a dosedependent fashion after
injection of endotoxin. ISH demonstrated that
COX-2 had distinct expression patterns in the
epithelium of middle ears with endotoxin-induced
OME. COX-2 expression, however, was not detected
in normal middle ears.
Conclusions:
COX-2 expression may be one factor contributing to
the development of OME.
| |
|
|
TOP PICKS
Sentinel
Lymph Node Biopsy & Superficial Oesophageal Cancer..?
Since its popularization in the management of head and
neck melanomas in early 1990s, the use of SLNB has been
gaining wide acceptance as a staging modality in several
head and neck malignancies. Hayashi H. et al recently (Surgery.
2006 Feb;139(2):224-35) experimentally
and clinically the evaluated the feasibility of
endoscopic CT Lymphography in superficial oesophageal
cancer and concluded it has potential in SLNB and
mapping of oesophageal lesion.
Abstract: BACKGROUND: To evaluate
experimentally and clinically the feasibility of a newly
developed technique of endoscopic computed tomography
(CT) lymphography with endoscopic submucosal injection
of iopamidol for esophageal sentinel lymph node (SLN)
mapping and biopsy examination. METHODS: Nine
anesthetized dogs underwent CT after endoscopic
submucosal injection of 2 mL iopamidol; 1.25-mm thick CT
images were obtained before and at 1, 3, 5, 7, and 10
minutes after contrast injection. Clinically, 12
patients with superficial esophageal cancer
(preoperative imaging stage: cT1, cN0) underwent CT
lymphography in a similar fashion at 1, 5, and 10
minutes after peritumoral injection, followed by radical
esophagectomy and regional lymph node dissection under
CT lymphography guidance. RESULTS: CT lymphography
visualized the draining lymphatic vessels and SLNs
within 5 minutes after contrast injection. All 14 SLNs
in dogs (average, 1.5 nodes per animal; range, 1-2) and
28 SLNs in patients (average, 2.3 nodes per patient;
range, 1-4) were found intraoperatively at the correct
location under CT lymphography guidance. Lymph node
metastasis could be detected with excellent sensitivity
and accuracy in this small number of patients with no
false-negative findings; metastasis was positive only in
the preoperatively identified SLNs in 4 patients and in
both SLNs and distant nodes in 1 patient, and was
negative in all resected nodes in the remaining 7
patients. CONCLUSIONS: Endoscopic CT lymphography
appears to allow accurate identification of direction
and locations of lymph flow and SLNs, and has the
potential clinical applicability for esophageal SLN
mapping and biopsy examination, but will require a large
study to determine its accuracy and usefulness
Coming Events of Importance to Otolaryngologists in
Africa...
-
8th International Otology Course of the Jean Causse
Ear Clinic
June 22-24, 2006; Béziers, France
-
110th American Academy of ORL,Head & Neck Surgery
Annual Meeting & OTO EXPO
September 17-20, 2006;
Toronto, Canada.
-
42nd South African ENT Congress joint meeting with
the British Association of Otolaryngology - Head &
Neck Surgery
October 29-November 1, 2006;
Cape Town, South Africa.
For more Worldwide otolaryngological events and conferences....Click
Here
Horizontal Canal BPPV - How Common.....?
A recent retrospective study, with
Evidence Based Medicine
rating of 4, from Turkey (Cakir BO et al,
Otolaryngol Head Neck Surg. 2006
Mar;134(3):451-454) examined the record of 169 patients
managed for BPPV over a 4 year period and discovered
that horizontal canal BPPV (H-BPPV) constitutes over 10%
Abstract: OBJECTIVE: To assess the correct
incidence of horizontal semicircular canal (H-SCC)
benign paroxysmal positional vertigo (BPPV). STUDY
DESIGN: Retrospective assessment of patients with BPPV.
METHODS: All patients with BPPV were included and the
rates of involvement of posterior, horizontal, and
anterior SCCs were determined. RESULTS: One hundred
sixty-nine patients with the diagnosis of BPPV were
evaluated. One hundred forty-four patients (85.2%) were
found to have posterior SCC (P-SCC) involvement, and
there were 20 patients (11.8%) with horizontal SCC (H-SCC)
and 2 patients (1.2%) with anterior SCC (A-SCC)
involvement. Three patients (1.8%) had simultaneous H-SCC
and P-SCC BPPV ipsilaterally. Geotropic nystagmus was
seen in 17 out of 23 patients (73.9%) in roll test, and
ageotropic nystagmus was seen in the remaining 6
patients (26.1%). CONCLUSION: H-SCC constitutes 13.6% of
all BPPV cases. H-SCC BPPV with geotropic nystagmus is
more common. H-SCC BPPV can coexist with ipsilateral P-SCC
BPPV. However, in some cases of H-SCC BPPV, Dix-Hallpike
maneuver can cause vertigo and horizontal nystagmus.
This may be confused with P-SCC BPPV. Therefore, the
roll test must be performed in all cases in addition to
Dix-Hallpike maneuver and both ears must be evaluated
with respect to all SCCs for BPPV

|
|
|
|
|
|
CLINICAL AUDIOGRAM OF THE WEEK |
A
23-year old female presented with progressive
bilateral hearing impairment of . 3 months
duration. She denied any previous head/ear trauma,
otorrhoea exposure to loud noise, or preceding
ingestion of known ototoxic drugs. There was
negative family history of hearing impairment. Clinical examination
including otoscopy was not remarkable. Her left
ear pure tone audiogram is shown in this picture.
You may want to
View audiogram for both ears
for clarity.
|
| |
|
|
What is the diagnosis?
- Parting Shot...
If you have an interesting
case to discuss or share with other Otolaryngologists
all over Africa, feel free to email
Me or at best go to
otolaryngology in Africa blogsite
and post your case
- Also, if you are among those who requested for a copy
of DODA at the last ORLSON Meeting @ Port Harcourt,
please take time to view the
DODA - FAQ page,
you should have received your copy by now. If you have
difficulty on using the program, please text
+2348032472069.
- An online video demonstration of doda is available
at
http://www.otolaryngologyinafrica.net/doda_video.htm
This
video takes about 30 - 45 minutes to fully load on a
broad band network the first time, but once fully
loaded could be viewed over and over again
- If you have anything you want to communicate with
other Otolaryngologists - news, request, etc, feel
free to email your communication to
orl-mailer@
otolaryngologyinafrica.net.
Your request will appear in member's page soon to be
created.
- Reviewers wanted for otolaryngology news journals
watch page. If you are an Otolaryngologist in Africa
and will like to be our journal reviewer, please feel
free to email
orl-mailer@otolaryngologyinafrica.net
Till Next Week,
Biodun
|
|
|
|
This is a free email newsletter
circulating to Otolaryngologists in Africa, and interested
Otolaryngologists elsewhere. If you know anyone interested
in receiving this free newsletter, feel free to forward a
copy to such person or encourage them to email
orl-mailer@otolaryngologyinafrica.net for
subscription
© Copyright Dr 'Biodun
Olusesi,
2005 - 2006 |